The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.
The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.
Market Segmentation
• Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
• Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
• Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
• Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
• End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
Regional Segmentation
• North America: U.S., Canada
• Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe
• Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America: Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World
Market Growth Drivers
• Increasing Use of NGS for Genetic Disorders
• Technological Advancements in NGS Sample Preparation Methods
• Rising Research Funding in the Field of Genomics
Market Challenges
• High Cost of Automated NGS Sample Preparation Instruments
• Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries
• Stringent Regulatory Standards
Market Opportunities
• Adoption of Automated NGS Sample Preparation in the Emerging Markets
• Rising Direct-to-Consumer Testing
Key Companies Profiled
Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc
Key Questions Answered in this Report:
• How is NGS sample preparation revolutionizing oncology?
• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
• How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
• How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
o Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
o Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
o Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
o End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the NGS sample preparation companies in the region of their operation?
• Who are the leading players with significant offerings in the global NGS sample preparation market?
• Which companies are anticipated to be highly disruptive in the future, and why?
Request a Sample - https://bisresearch.com/requestsample?id=1249type=download
